GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+25.08%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$311M
AUM Growth
+$311M
(+79%)
Cap. Flow
+$122M
Cap. Flow
% of AUM
39.1%
Top 10 Holdings %
Top 10 Hldgs %
41.8%
Holding
78
New
28
Increased
24
Reduced
11
Closed
7
Top Buys
| 1 |
MoonLake Immunotherapeutics
MLTX
|
$11.1M |
| 2 |
TG Therapeutics
TGTX
|
$8.75M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$7.64M |
| 4 |
Roivant Sciences
ROIV
|
$7.38M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$6.9M |
Top Sells
| 1 |
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
|
$6.76M |
| 2 |
Krystal Biotech
KRYS
|
$6.41M |
| 3 |
argenx
ARGX
|
$5.71M |
| 4 |
Taysha Gene Therapies
TSHA
|
$3.3M |
| 5 |
Structure Therapeutics
GPCR
|
$3.21M |
Sector Composition
| 1 | Healthcare | 99.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Ascendis Pharma
ASND
$12.1B
| – | – |
-20,000
| Closed | -$2.52M |
|
|
77
argenx
ARGX
$44.2B
| – | – |
-15,000
| Closed | -$5.71M |
|
78
Amylyx Pharmaceuticals
AMLX
$877M
| – | – |
0
| – | – |
|